Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Fukuda Denshi Co's Revenue for the
three
months ended in Mar. 2026 was 円40,840 Mil. Fukuda Denshi Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was 円31,409 Mil.
Hence, Fukuda Denshi Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.30.
Fukuda Denshi Co (TSE:6960) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Fukuda Denshi Co Receivables Turnover Related Terms
Fukuda Denshi Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6960 vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Fukuda Denshi Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (TSE:6960) has a Receivables Turnover of 1.30 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Fukuda Denshi Co and its competitors. According to the industry distribution chart, Fukuda Denshi Co ranks #550 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 67.7%.
Is Fukuda Denshi Co's Receivables Turnover too high?
Fukuda Denshi Co's current Receivables Turnover is 1.30. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Fukuda Denshi Co's value of 1.30 is 76.4% below this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #550 out of 812 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fukuda Denshi Co has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #550 out of 812 companies for Receivables Turnover. This places Fukuda Denshi Co in the lower half of its industry. The industry median Receivables Turnover is 5.51. Fukuda Denshi Co's value of 1.30 is 76.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current Receivables Turnover of 1.30 is 76.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current Receivables Turnover is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,343.12, compared to a current price of 円11,700.00 — trading 59.3% above its estimated fair value. The current Receivables Turnover is 1.30 and 76.4% below the Medical Devices & Instruments industry median of 5.51. Fukuda Denshi Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current Receivables Turnover is 1.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円11,700.00 is trading 59.3% above its estimated GF Value™ of 円7,343.12.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
Receivables Turnover: 1.30
GF Value™: 円7,343.12 vs. price of 円11,700.00 (59.3% above fair value)
Industry Position: 76.4% below the Medical Devices & Instruments median (#550 of 812)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
85GF Score
Get the complete analysis for TSE:6960
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
